Trade Summary

5 days ago, Santos Da Silva Jorge, serving as CEO at Moonlake Immunotherapeutics (MLTX), sold 150,000 shares at $18.35 per share, for a total transaction value of $2,752,163.00. Following this transaction, Santos Da Silva Jorge now holds 2,924,893 shares of MLTX.

This sale represents a 5.00% decrease in Santos Da Silva Jorge's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, April 10, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, April 14, 2026, 4 days after the trade was made.

Moonlake Immunotherapeutics operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.